• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    S&P Biotech Bull 3X Direxion (NY: LABU )

    132.13 +2.42 (+1.87%)
    Streaming Delayed Price Updated: 9:31 AM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 115,214
    Open 132.47
    Bid (Size) 131.95 (1)
    Ask (Size) 132.24 (2)
    Prev. Close 129.71
    Today's Range 131.61 - 132.99
    52wk Range 48.40 - 176.99
    Shares Outstanding 84,744
    Dividend Yield 0.00%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win
    Wall Street piled up strong gains in yesterday’s trading session, with the S&P 500 hitting the 25th record high this year and the Nasdaq Composite Index touching another record. 
    Via Talk Markets
    Topics ETFs Stocks
    Exposures US Equities
    The 3 Best Leveraged ETFs for April 2024
    If you want to speculate on baskets of securities, then these best leveraged ETFs for April could be what the doctor ordered. 
    Via InvestorPlace
    Topics ETFs

    Performance

    YTD
    +5.08%
    +5.08%
    1 Month
    +17.33%
    +17.33%
    3 Month
    +48.74%
    +48.74%
    6 Month
    +11.71%
    +11.71%
    1 Year
    +12.16%
    +12.16%

    More News

    Read More
    5 Best-Performing Leveraged ETFs Of February
    Via Talk Markets
    Topics ETFs Stocks
    Exposures US Equities
    Stocks To Watch This Week - Sunday, Feb. 11
    Via Talk Markets
    Topics ETFs
    Want Diversified Upside in Biotechnology? Check out LABU
    Via MarketBeat
    Topics ETFs Stocks
    Exposures US Equities
    Sector Rotation
    Via Talk Markets
    The Week Ahead Commentary - Saturday, Feb. 4
    Via Talk Markets
    J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
    Via Talk Markets
    3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty
    Via InvestorPlace
    The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)…
    Via Talk Markets
    3 Biotech Stocks to Buy That Are Under Severe Pressure
    Via InvestorPlace
    5 Best Leveraged ETFs of Last Week
    Via Talk Markets
    5 Best-Performing Leveraged ETFs of August
    Via Talk Markets
    The Week In Charts: Figure This Out And You’ll Own The World
    Via Talk Markets
    The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs
    Via Talk Markets
    The Week In Charts: Trading Stuff Part 2-IPOs, ETFs, And, The Secret To Trading
    Via Talk Markets
    These Were The Stocks David Green Discussed On His Show This Morning
    Via Benzinga
    The Week In Charts-Volatility: Rabbit Hole Or Holy Grail?
    Via Talk Markets
    A Biotech ETF For Aggressive, Risk-Tolerant Investors
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    A Biotech ETF For Aggressive, Risk-Tolerant Investors
    Via Benzinga
    Exposures Product Safety
    CrowdStrike Stock Earnings Trade
    Via Talk Markets
    This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.